Summit Therapeutics revealed positive Western data last week from a Phase 3 trial of lung cancer candidate ivonescimab. In a flipped geographical clinical trials landscape, what more will be required ...
Correspondence to Dr Dirk-Jan Slebos, Department of Pulmonary diseases AA11, University Medical Center Groningen, University of Groningen, PO Box 30001, Groningen 9700 RB, The Netherlands; ...
AMD remains a top long-term AI infrastructure play, leveraging disaggregated inference architecture and superior tokenomics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results